Skip to content

Use of Agave sisalana fibre (Sisal Fibres) Suture Material in sadyovrana (Traumatic Wounds)

An Open Labelled Randomized Controlled clinical Study on Agave sisalana Fibre in Sadyovrana as a Suture Material - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062248
Enrollment
40
Registered
2024-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

None listed

Sponsors

Dr Harsha M Kencharadder
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age group between 18 to 60years. 2.Irrespective of Gender, Occupation, Place and Socio- economic status. 3.Subjects suffering with incised fresh wound measuring within 5x1x1 cm.

Exclusion criteria

Exclusion criteria: 1.Infected or contaminated wounds. 2.Animal bites. 3.Wounds involving significant underlying vital structures. 4.Subjects with any bleeding disorders. 5.HIV, HBsAg, Uncontrolled type 2 DM, HTN and any other systemic disorders. 6.Burns. 7.Wounds caused by Alkalis and Poison. 8.Wounds associated with fracture. 9.Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
To assess the effect of agave fibres as suture material in human skin in traumatic woundTimepoint: Duration of the study Incised wound will be assessed before and after the suturing on the 1st,7th and 14th day. Hence, the study duration will be 14 days. Follow up - On the completion of the treatment the subjects will be asked to visit the OPD on 28th day to rule out any complications.

Secondary

MeasureTime frame
To give economically & human skin friendly suture material to surgical fieldTimepoint: Duration of the study -Incised wound will be assessed before & after the suturing on the 1st,7th & 14th day. Hence, the study duration will be 14 days. Follow up - On the completion of the treatment the subjects will be asked to visit the OPD on 28th day to rule out any complications.

Countries

India

Contacts

Public ContactDr Poornima Jalawadi

Jagadguru Sri Shivarathreeshwara Medical College and hospital Mysuru

jalawadi.poornim@gmail.com9663591100

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026